批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/10/06 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/11/06 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/11/16 |
SUPPL-2(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/11/29 |
ORIG-1(原始申请) |
Approval |
Not Applicable |
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;EQ 10MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
001 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 10MG BASE |
Prescription |
Yes |
No |
AB |
2004/01/30
|
PHARMACIA |
200465 |
004 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
004 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
004 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
001 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;EQ 20MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
002 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 20MG BASE |
Prescription |
Yes |
No |
AB |
2004/01/30
|
PHARMACIA |
200465 |
005 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
005 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
005 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
002 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;EQ 40MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
003 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 40MG BASE |
Prescription |
Yes |
No |
AB |
2004/01/30
|
PHARMACIA |
200465 |
006 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
006 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
006 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
003 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 5MG BASE;EQ 80MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
004 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 80MG BASE |
Prescription |
Yes |
No |
AB |
2004/01/30
|
PHARMACIA |
200465 |
007 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
007 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
007 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
004 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 5MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;EQ 10MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
005 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 10MG BASE |
Prescription |
Yes |
No |
AB |
2004/01/30
|
PHARMACIA |
200465 |
008 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
008 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
008 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
005 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 10MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;EQ 20MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
006 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 20MG BASE |
Prescription |
Yes |
No |
AB |
2004/01/30
|
PHARMACIA |
200465 |
009 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
009 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
009 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
006 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 20MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;EQ 40MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
007 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 40MG BASE |
Prescription |
Yes |
No |
AB |
2004/01/30
|
PHARMACIA |
200465 |
010 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
010 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
010 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
007 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 40MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |
活性成分:AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM 剂型/给药途径:TABLET;ORAL 规格:EQ 10MG BASE;EQ 80MG BASE 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021540 |
008 |
NDA |
CADUET |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 80MG BASE |
Prescription |
Yes |
Yes |
AB |
2004/01/30
|
PHARMACIA |
200465 |
011 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2013/11/29
|
MYLAN |
203874 |
011 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2014/03/07
|
DR REDDYS |
207762 |
011 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2019/01/11
|
ZYDUS PHARMS |
205199 |
008 |
ANDA |
AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM |
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM |
TABLET;ORAL |
EQ 10MG BASE;EQ 80MG BASE |
Prescription |
No |
No |
AB |
2019/11/18
|
APOTEX |